Senior insider sale
Chief Commercial Officer at CYMABAY THERAPEUTICS, INC. — senior position signals high conviction
$455.4K
18K shares
What this filing means
DORLING JANET plans to sell 18K shares of CYMABAY THERAPEUTICS, INC. valued at approximately $455.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2024ACC: 0001950047-24-000830
Officer· Chief Commercial Officer
Since Aug 2019
18K
Shares to sell
$455.4K
Approx. market value
6K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
2/12/2024
6KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Stock Option Exercise Cash | 6K | — |
| Total | 6K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6K
Market value
$143.1K
1/10/2024
—Completed
Units to sell
6K
Market value
$120.4K
12/11/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
6K
Market value
$191.8K
2/12/2024
Total
Units
18K
Value
$455.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/10/2024 | 6K | $143.1K | — | Completed |
12/11/2023 | 6K | $120.4K | — | Completed |
| Planned — Approximate Date | ||||
2/12/2024 | 6K | $191.8K | NASDAQ | Planned |
| Total | 18K | $455.4K | ||